- About Us
- Clinical Trials
- Clinical Guidelines
- News + Events
- Contact Us
TORONTO and BOSTON, Aug. 08, 2016 (GLOBE NEWSWIRE) — Bionik Laboratories Corp. (OTCQX:BNKL) (“Bionik” or the “Company”), a global pioneering robotics company focused on providing rehabilitation solutions to individuals with neurological disorders, announced today that it has appointed Timothy A. McCarthy to its Management Team as Chief Commercialization Officer. Mr. McCarthy is a well-established and successful commercial leader in medical and healthcare technology. The Company also announced the addition of Steven L. Brown and Jon C. King to its newly formed global commercialization team. Read more
Non-invasive Brain Stimulation and Human Motor Control Laboratory at Burke Medical Research Institute & Well Cornell Medicine.
Space is Limited
Pre-requisite: Minimum bachelor’s degree in a related field
Click Here to Register at Eventbrite.com
TORONTO and BOSTON, June 14, 2016 (GLOBE NEWSWIRE) — Bionik Laboratories, Inc. (OTCQX:BNKL) (“Bionik” or the “Company”), a global pioneering robotics company focused on providing rehabilitation solutions to individuals with neurological disorders, announced today that the study led by Newcastle University under the auspices of the National Institute for Health Research (NIHR) HTA Programme has achieved 50 percent enrollment for its multicenter, randomized controlled RATULS trial. The National Institute of Health Research (NIHR) is the research arm of the NHS in the UK which specifically commissioned this study having identified that robotic rehabilitation was necessary to further research. The investigating team expects to complete the study in 2018 and publish the results in 2019. Read more
Toronto, ON – April 21, 2016 – Bionik Laboratories Corp. (OTCQX: BNKL), a global pioneering robotics company focused on providing rehabilitation solutions to individuals with neurological disorders (“Bionik” or the “Company”), announced today it has acquired all of the outstanding shares and, accordingly, all assets and liabilities of Interactive Motion Technologies, Inc. (“IMT”), a Boston, Massachusetts-based global pioneer and leader in providing effective robotic tools for neurorehabilitation. Read more
Peter joined our Interactive Motion Technologies family in 2010 and has been a steadfast force ever since. He loved this work. Peter was a dynamic member of the sales team, and though he was semi-retired, he remained extremely active in promoting robotic rehabilitation to anyone who would listen. He firmly believed in the value of this novel approach to rehabilitation and wanted to make it available to people everywhere, never hesitating to jump on a plane or driving endless miles for a chance to share his excitement about InMotion Robots. Peter took on major projects and eagerly advancing everything he did. He was full of ideas, embraced the latest technology and tools in his work, and was always learning.
I cannot express in words my admiration of Peter’s enthusiasm, dedication, and passion and we are honored to have had him as part of the InMotion family for this short 5-year span. We are also grateful to his devoted wife, Janet, for lending him to us during his golden retirement years.
The purpose of this course is to review basic neuroscience concepts and clinical evidence on the application of robotics in rehabilitation, as well as discuss novel approaches to augment outcomes further. The course employs a highly interactive learning environment to offer participants the opportunity to ask the experts after reviewing a set of educational videos.